[go: up one dir, main page]

MX2017006748A - Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades. - Google Patents

Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades.

Info

Publication number
MX2017006748A
MX2017006748A MX2017006748A MX2017006748A MX2017006748A MX 2017006748 A MX2017006748 A MX 2017006748A MX 2017006748 A MX2017006748 A MX 2017006748A MX 2017006748 A MX2017006748 A MX 2017006748A MX 2017006748 A MX2017006748 A MX 2017006748A
Authority
MX
Mexico
Prior art keywords
disease
symptoms
treatment
amino acid
acid compositions
Prior art date
Application number
MX2017006748A
Other languages
English (en)
Inventor
B Dennison Daniel
Vidyasagar Sadasivan
J Gatto Stephen
Original Assignee
Entrinsic Health Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entrinsic Health Solutions Inc filed Critical Entrinsic Health Solutions Inc
Publication of MX2017006748A publication Critical patent/MX2017006748A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La invención objeto proporciona composiciones terapéuticas, y sus usos para el tratamiento o mejora de síntomas de una enfermedad seleccionada del grupo que consiste de: infección por virus de ébola, infección por HIV, ataxia, enteropatía ambiental, cáncer, resaca, enfermedad inflamatoria y diarrea epidémica porcina. En modalidades preferidas, la composición incluye una combinación de uno o más aminoácidos seleccionados del grupo que comprende de lisina, acido aspártico, glicina, isoleucina, treonina, tirosina, valina, triptófano, asparagina y/o serina.
MX2017006748A 2014-11-24 2015-11-19 Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades. MX2017006748A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462083698P 2014-11-24 2014-11-24
US201562138051P 2015-03-25 2015-03-25
PCT/US2015/061462 WO2016085735A1 (en) 2014-11-24 2015-11-19 Amino acid compositions for the treatment of symptoms of disease

Publications (1)

Publication Number Publication Date
MX2017006748A true MX2017006748A (es) 2017-08-28

Family

ID=56074902

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017006748A MX2017006748A (es) 2014-11-24 2015-11-19 Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades.

Country Status (8)

Country Link
US (5) US20170326088A1 (es)
EP (3) EP3459540A1 (es)
JP (1) JP2017535591A (es)
CN (1) CN107106527B (es)
BR (1) BR112017010832A2 (es)
CA (1) CA2968831A1 (es)
MX (1) MX2017006748A (es)
WO (1) WO2016085735A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018067717A1 (en) * 2016-10-04 2018-04-12 University Of Florida Research Foundation, Incorporated Amino acid compositions and uses thereof
JP2019043861A (ja) * 2017-08-30 2019-03-22 アサヒグループホールディングス株式会社 乳酸／ピルビン酸比の改善用組成物
WO2019070753A1 (en) * 2017-10-02 2019-04-11 University Of Florida Research Foundation, Incorporated AMINO ACID COMPOSITIONS AND METHODS FOR TREATING DIARRHEA
CN112188891A (zh) * 2018-04-04 2021-01-05 佛罗里达大学研究基金会公司 用于治疗皮肤的组合物
IT201800005599A1 (it) * 2018-05-22 2019-11-22 Lente a contatto morbida
CN108434304A (zh) * 2018-05-23 2018-08-24 北京雄九医学研究院 防癌抗癌中药的制备方法
US20230045151A1 (en) * 2020-01-13 2023-02-09 Monash University Compositions and methods
AU2021300188A1 (en) * 2020-07-02 2023-02-02 Amilyfe, Llc Formulations for promoting hydration and methods of use thereof
US11878073B1 (en) 2022-09-20 2024-01-23 Entrinsic, LLC Generation of hydration-targeted formulations and methods of use therein

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3532204B2 (ja) 1991-03-05 2004-05-31 アラダイム コーポレーション 流量計の圧力センサのドリフトオフセットを補正する方法および装置
ES2284226T3 (es) 1991-07-02 2007-11-01 Nektar Therapeutics Dispositivo para proporcionar medicamentos en aerosol.
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5558085A (en) 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
US5934272A (en) 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
AU710527B2 (en) 1995-02-23 1999-09-23 Novartis Nutrition Ag Amino acid compositions and use thereof in clinical nutrition
EP0951300A4 (en) 1996-12-31 2006-07-26 Nektar Therapeutics PROCESS FOR SPRAY DRYING OF SOLUTIONS OF HYDROPHILIC DRUGS WITH HYDROPHILIC BINDERS AND COMPOSITIONS MADE BY THIS METHOD
WO2000029620A1 (en) 1998-11-13 2000-05-25 Children's Hospital Of Los Angeles Methods of facilitating vascular growth
DK1250058T3 (da) 2000-01-14 2009-05-04 Epax As Marin lipidsammensætning til fodring af vandorganismer
GB0009056D0 (en) 2000-04-12 2000-05-31 Nestle Sa Composition comprising free amino acids
US7063865B2 (en) * 2002-05-10 2006-06-20 Jeremy Park Jones Composition and method for substantially reducing the deleterious effects of alcohol on the body
US20040087490A1 (en) * 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US20070010459A1 (en) 2005-01-14 2007-01-11 Ying Liu Application of asiatic acid and its derivatives to treat pulmonary fibrosis
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
US20110183040A1 (en) * 2007-08-03 2011-07-28 Ermolin Gennady A Amino Acid and Peptide Products
IT1396935B1 (it) 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
IT1397861B1 (it) * 2010-01-27 2013-02-04 Ambrosialab Srl Metodo e composizioni per l'applicazione di aminoacidi sulla pelle mediante un mezzo anidro
GB201012539D0 (en) 2010-07-27 2010-09-08 Savantium Ltd Nutritional compositions
CN103153298B (zh) 2010-09-24 2015-11-25 佛罗里达大学研究基金会有限公司 用于改善胃肠功能的材料和方法
BR112013026082A2 (pt) * 2011-04-12 2019-09-24 Nestec Sa composições nutricionais incluindo ácidos graxos de cadeia ramificada para melhorar função de barreira intestinal
DK2782566T3 (da) * 2011-11-21 2021-02-08 The Inst For Ethnomedicine L-serin til anvendelse ved behandling af neurodegenerative lidelser
KR102262179B1 (ko) * 2012-02-08 2021-06-07 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 설사를 치료하기 위한 물질 및 방법
WO2014062683A1 (en) * 2012-10-15 2014-04-24 University Of Florida Research Foundation, Inc. Materials and methods for prevention and treatment of diarrhea and inflammation in the gastrointestinal tract

Also Published As

Publication number Publication date
CA2968831A1 (en) 2016-06-02
EP3459540A1 (en) 2019-03-27
EP3223809A4 (en) 2018-08-15
EP3616689A1 (en) 2020-03-04
US11357747B2 (en) 2022-06-14
US20200368194A1 (en) 2020-11-26
US20170326088A1 (en) 2017-11-16
WO2016085735A1 (en) 2016-06-02
US20180289648A1 (en) 2018-10-11
US12161614B2 (en) 2024-12-10
JP2017535591A (ja) 2017-11-30
US20250049744A1 (en) 2025-02-13
CN107106527A (zh) 2017-08-29
US20220347143A1 (en) 2022-11-03
US10758506B2 (en) 2020-09-01
EP3223809A1 (en) 2017-10-04
CN107106527B (zh) 2020-11-24
BR112017010832A2 (pt) 2017-12-26

Similar Documents

Publication Publication Date Title
MX2017006748A (es) Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades.
CL2016001405A1 (es) A peptide mixture
EA201790465A1 (ru) Антитела, композиции и применение
CY1117214T1 (el) Συνθεση για ελεγχομενη διεγερση των ωοθηκων
EP4417256A3 (en) Materials and methods for improving lung function
EA201790273A1 (ru) Флагеллиновые композиции и их применение
UA118167C2 (uk) Пептид та його застосування
MX359201B (es) Polipeptidos que se unen al complemento humano 5 (c5).
EA201692529A1 (ru) Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов
PH12017500393A1 (en) Pyrrolopyrimidines for use in influenza virus infection
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
CL2017002729A1 (es) Proteína de unión a rgma y su uso
EA201692552A1 (ru) МОДИФИЦИРОВАННЫЕ МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHbp
EA201990298A1 (ru) Способы и композиции для лечения рака
MX378754B (es) Métodos y reactivos para la prevención y/o el tratamiento de infecciones.
MX2019006943A (es) Polipéptidos para manejo de infecciones virales.
MX2022011972A (es) Composiciones que comprenden anticuerpos contra il6r para el tratamiento de la uveitis y el edema macular, y metodos de uso de las mismas.
MX2010010457A (es) Vectores recombinantes de rinovirus.
EA201791937A1 (ru) Противовоспалительные полипептиды
EA201891527A1 (ru) Композиции и способы обнаружения и лечения рака пищевода
CU20210061A7 (es) Composición vacunal que comprende el dominio alfa 3 de mica/b para el tratamiento del cáncer
MX373409B (es) Composiciones para fibras de queratina.
CO6592047A2 (es) Formulación tópica oftálmica de péptidos
CY1118967T1 (el) Φαρμακευτικες συνθεσεις υψηλης δοσης βιοτινης
DK3658133T3 (da) Sammensætninger omfattende aminosyrer til anvendelse ved behandling af fedme